The Pharma Data

JANUARY 18, 2021

BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, is pleased to announce that Health Canada has confirmed that 2-bromo-LSD is not a controlled substance. VANCOUVER, Jan.

Containment 40

Containment Regulation Production Drug Delivery 40

The Pharma Data

DECEMBER 28, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About BetterLife Pharma Inc.

Containment 52

Containment Drug Delivery Compliance Marketing 52

FDA Law Blog

MARCH 12, 2024

In fact, federal law and regulation appear to require AbbVie to list these patents.” Kaleo also delisted, but not without noting that “the decision to list each of these patents was proper, consistent, and required by the applicable statutes, regulations, and FDA’s guidance available at the time of listing.”

Drugs 59

Drugs Drug Delivery Systems Regulation Production 59

The Pharma Data

DECEMBER 14, 2020

BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLC ’s (“Transcend”) manufacturing patent “Process of synthesizing 2-Bromo-LSD.”.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

The Pharma Data

NOVEMBER 26, 2020

This novel nanoparticle formation technology provides hope for improving the possibilities and probabilities of developing better medicines for patients and it expands Nanoform’s reach into the growing biological market. ” Prof. ” Prof. Finnish time. About Nanoform.

Containment 52

Containment Medicine Bioavailability Clinical Trials 52

The Pharma Data

JANUARY 3, 2021

The information in the press release is information that Nanoform is obliged to make public pursuant to the EU Market Abuse Regulation. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. Finnish time.

Containment 52

Containment Bioavailability Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 4, 2020

Thoresen holds a law degree from the top-ranked University of Oslo and core competencies in strategy and organizational development, operational execution, and industry and government relations. About XPhyto Therapeutics Corp. XPhyto Therapeutics Corp. Forward looking statements. SOURCE: XPhyto Therapeutics Corp.

Drug Delivery 40

Drug Delivery Production Manufacturing Life Science 40

The Pharma Data

JANUARY 17, 2021

The Company is on the cusp of transformational change as product development programs advance from the laboratory to the clinic. In addition to COVID-19 products, XPhyto and its partner 3a, are developing and commercializing a portfolio of low-cost oral biosensors. Diagnostics. “2020 was a very productive year for XPhyto.

Production 40

Production Drug Delivery Development Drugs 40

XTalks

AUGUST 30, 2022

Due to consistent changes in pharmaceutical regulation, pandemic-related disturbances and the ongoing effects of digitization, visionary leaders could find themselves co-constructing their vision. Developing strategies can often fall under the responsibilities of directors and managers of companies. Bureaucratic Leadership.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105

The Pharma Data

OCTOBER 27, 2020

is a research and development company that develops topical and transdermal consumer products including DermSafe, all made with patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. Ovation Science Inc.

Sales 52

Sales Production Drug Delivery Development 52

Delveinsight

JANUARY 22, 2021

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. The company expects topline the phase III trial results by the second half of 2022.

Marketing 65

Marketing Drugs Antibody Compliance 65

The Pharma Data

JANUARY 15, 2021

develop this rare disease each year.[6] Global Medical Head/Clinical Leader, Hematology & Oncology, Janssen Research & Development, LLC. and Genmab A/S entered into a worldwide agreement, which granted Janssen an exclusive license to develop, manufacture and commercialize daratumumab. The most common adverse reactions (?20

FDA Approval 52

FDA Approval Production Research Doctors 52

The Pharma Data

JANUARY 27, 2021

Construction of commercial drug manufacturing facility in Germany. Development of oral biosensor and contract development & manufacturing. Psychedelic transdermal and sublingual drug formulation development. Four clinical studies in neurological indications in 2021.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

The Pharma Data

JANUARY 25, 2021

Optimised formulations have been developed for the two internal pipeline programmes, MTD211 and MTD219, with the former undergoing and the latter shortly to beginin vivostudies. ” This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR). Panobinostat Licence.

Containment 52

Containment Drug Delivery Licensing Licensing 52

The Pharma Data

JANUARY 27, 2021

BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, announces it has entered into an agreement with Eurofins Discovery for TD-0148A’s U.S. VANCOUVER, Jan. Source link.

In-Vitro 52

In-Vitro Containment Drugs Production 52

The Pharma Data

APRIL 27, 2021

A Minipump Continuous Drug Infusion Dog Model System to Identify Candidate Drugs and Drug Delivery Rates for Intracameral IOP-lowering Implants. A Retrospective Analysis: Visual Field Progression and Visual Acuity following Administration of Brimonidine Drug Delivery System. Sunday, May 2. Monday, May 3.

Research 40

Research Drug Delivery Systems Drug Delivery Production 40

Pharmaceutical Technology

FEBRUARY 3, 2023

In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.

Contamination 130

Contamination Manufacturing Containment Production 130